SIMFO
Desconocido
CAST: Active Monitoring of Cancer As An Alternative To Surgery
SIMFO SPEZIELLE IMMUNOLOGIE FORSCHUNG UND ENTWICKLUNG GMBH
participó en un
H2020:
H2020-MSCA-ITN-2019
When a patient is discovered to have cancer, one of the primary goals is to have the tumour removed by surgery. Although
this provides excel...
2019-09-11 - 2024-10-31 | Financiado
2019-09-11 - 2024-10-31 | Financiado
MAINTRAC-Auto: MAINTRAC Auto Automatization and validation of a liquid biopsy assay Maintrac AUTO CTC analyser f...
SIMFO SPEZIELLE IMMUNOLOGIE FORSCHUNG UND ENTWICKLUNG GMBH
tramitó un
H2020:
H2020-SMEInst-2014-2015
Worldwide cancer is one of the leading causes of death and the need for more effective therapies is crucial. New precision diagnostics can i...
2016-02-12 - 2016-08-31 | Financiado
2016-02-12 - 2016-08-31 | Financiado
* No se disponen de datos de la empresa actual.